MATRIX EDC in US rescue study
Data MATRIX team starts an international phase I study to be conducted in Russia and the USA.
MATRIX EDC was chosen as the primary technology solution for data collection and management and complies with all necessary requirements. This will be a multicenter open-label trial for patients with hematological malignancies. The study is expected to enroll up to 110 participants.
This project is already the third rescue study for Data MATRIX where the team is delegated with responsibility for providing data collection and management services via MATRIX EDC after unsuccessful experience with another service provider. ‘We appreciate being repeatedly chosen by American CROs and sponsors to provide timely and cost-effective solutions, even in such a competitive market as the USA’, comments Data MATRIX CEO Ivan Dobromyslov.
The study will be completed in 2020.